Balu Forge Industries Ltd

Contract win

• BFIL wins multi-month contract for 155mm ERFB BB/BT shells; pilot 10,000 units, then ongoing monthly supplies.
• First purchase order from an Indian ammunition player.
• Pilot supply to commence; BFIL positioned as leading private indigenised defence supplier.

Operational and capabilities

• NATO certification secured; mass production at Belgaum facility for 152 mm and 155 mm M107 projectiles.
• Fully automated Belgaum plant supports Ready to Fill standard projectiles.

Strategic impact

• Expansion into defence consumables; advancing next-generation artillery and multi-alloy forgings.

Issue Overview

• Type and securities: Preferential issue of equity shares and convertible warrants.
• Total issue size disclosed; no undersubscription reported.
• Main objectives: capex (plant and machinery), working capital, general corporate purposes.
• Net proceeds not stated in document.

Utilisation of Proceeds

• Utilisation as per offer: aligned with disclosed objects.
• Deviations: none observed.
• P&M object: fully utilised; funds used for machinery purchase.
• Working capital object: fully utilised; funds used to procure raw materials.
• GCP object: fully utilised; used for raw materials, interest, taxes, consultancy.
• Unutilised funds: nil.

Governance and Compliance

• Approvals obtained: statutory approvals including BSE principal approval.
• Material viability events: none reported.
• Other information: none reported.

General Corporate Purpose

• GCP utilised amount: 124.20 crore; for raw materials, interest, advance tax, consultancy charges.
• Board approval for allocation: not explicitly stated in the report.

Filing Status

• There is no deviation in use of funds from preferential issue for the quarter ended 30 June 2026.
• Audit Committee approved the report by circular resolution on August 14, 2026.

Meeting Details

• Date: 12 August 2026; time not disclosed.
• Type and mode: Board of Directors meeting; mode not disclosed.
• Organiser: Board of Directors meeting of Balu Forge Industries Limited.
• Purpose: consider raising funds and approve unaudited results for quarter ended 30 June 2026.
• Key participants: Board of Directors.
• Recording: no details provided on recording or presentation availability.

Meeting Details

• Date: August 20, 2026; plant visit for investors/analysts.
• Interaction type: Group; mode: Physical.
• Plant visits at Belgaum and Hattargi.
• Followed by a management meet with Analysts/Investors.

Participants

• Key company participant: Managing Director (MD).

Purpose

• Discuss the company's business and publicly available information.

Additional Notes

• Information will be posted on the company's website.

FCCB issuance

• Special resolution to issue FCCBs up to USD 60 million.
• FCCBs may be denominated in foreign currency or INR.
• Issuance via private placement or other permitted method.
• Pricing to be determined by Board; independent valuers may be appointed.
• Discount on floor price up to 5% for QIP, as permitted.
• Conversion into equity to be on terms set by the Board.
• Equity shares upon conversion rank pari passu with existing shares.
• Board authorized to finalize terms, timing, and documents.
• Promoter/KMP interest: none disclosed in resolution.
• Results will be announced by Sept 5, 2026.
• Proceeds to fund working capital, capex, debt refinance, and general corporate purposes.

Borrowing limit

• Special resolution to authorize borrowing up to ₹1,000 crore.
• Total outstanding borrowings may exceed paid-up capital and reserves.
• Borrowings may include loans, FCCBs, debentures, and other debt instruments.
• Promoter/KMP interest: none disclosed.
• Board/Committee empowered to act within regulatory requirements.
• Board date of approval: August 12, 2026.

Charges on assets

• Special resolution to create/renew charges on assets up to ₹1,000 crore.
• Covers movable and immovable property to secure borrowings.
• Includes existing and future assets; security for debt instruments.
• Rank pari passu with existing charges.
• Promoter/KMP interest: none disclosed.
• Documents to be made available for inspection.
• Date Aug 12, 2026.

Voting status

• Item 1: Voting results to be announced by Sept 5, 2026.
• Item 2: Voting results to be announced by Sept 5, 2026.
• Item 3: Voting results to be announced by Sept 5, 2026.

Shareholding impact

• FCCBs convertible; no control change anticipated.
• Equity upon conversion to rank pari passu.
• Pricing/offer terms to be determined; investors may be eligible.
• No promoter/KMP interest in item 1.

Financial highlights

• Total income for Q1 FY27: Rs 3,046 Mn, up 29.7% YoY.
• Revenue from operations Rs 3,007 Mn in Q1 FY27, up 29.0% YoY.
• EBITDA Rs 848 Mn; margin 28.2%, up 17.3% YoY.
• PAT Rs 661 Mn; margin 21.7%, up 15.9% YoY.
• EPS Rs 5.49, up 8.9% YoY.

Strategic and operational developments

• Maiden aerospace order from the United States marks entry into regulated aerospace supply chain.
• Incremental defence orders, including large-calibre artillery shells, expand precision defence capabilities.
• Fully automated, indigenously developed production lines support scale and efficiency.
• Upcoming commissioning of capacities with heavy forging presses and advanced machining lines.
• Capex supports higher-margin, niche engineering applications across aerospace, defence and energy-transition sectors.
• Headroom to scale order book and onboard global clients through enhanced automation and R&D.